tiprankstipranks
Trending News
More News >
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market

Biolidics Ltd. (8YY) Ratios

Compare
1 Followers

Biolidics Ltd. Ratios

SG:8YY's free cash flow for Q2 2025 was S$0.28. For the 2025 fiscal year, SG:8YY's free cash flow was decreased by S$ and operating cash flow was S$-0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.58 0.22 0.99 2.53 5.65
Quick Ratio
0.58 0.22 0.98 1.90 4.95
Cash Ratio
0.21 0.10 0.84 1.64 4.66
Solvency Ratio
-0.28 -0.84 -1.05 -0.52 -0.38
Operating Cash Flow Ratio
-1.87 -1.02 -0.51 -1.92 -1.06
Short-Term Operating Cash Flow Coverage
-4.57 -1.82 -2.92 -4.55 -2.80
Net Current Asset Value
S$ -2.86MS$ -2.24MS$ -1.86MS$ -2.98MS$ 2.46M
Leverage Ratios
Debt-to-Assets Ratio
0.52 2.97 0.49 0.37 0.28
Debt-to-Equity Ratio
2.26 -1.02 -1.78 1.82 0.64
Debt-to-Capital Ratio
0.69 59.50 2.27 0.65 0.39
Long-Term Debt-to-Capital Ratio
0.63 -0.45 338.60 0.54 0.31
Financial Leverage Ratio
4.32 -0.34 -3.61 4.90 2.27
Debt Service Coverage Ratio
-1.69 -0.98 -6.59 -3.68 -3.56
Interest Coverage Ratio
-33.36 -8.97 -18.07 -15.92 -36.31
Debt to Market Cap
0.04 0.22 0.41 0.08 0.06
Interest Debt Per Share
<0.01 <0.01 0.01 0.02 0.02
Net Debt to EBITDA
-2.21 -1.58 0.24 -0.06 1.53
Profitability Margins
Gross Profit Margin
27.65%52.71%46.73%20.87%41.03%
EBIT Margin
-57.56%-506.50%-388.99%-252.03%-45.42%
EBITDA Margin
-56.66%-419.49%-341.46%-197.93%-37.91%
Operating Profit Margin
-26.35%-359.57%-121.94%-143.13%-49.83%
Pretax Profit Margin
-58.35%-546.57%-395.74%-261.02%-50.51%
Net Profit Margin
-58.97%-898.19%-376.62%-258.60%-50.15%
Continuous Operations Profit Margin
-58.97%-546.57%-376.62%-258.60%-50.15%
Net Income Per EBT
101.06%164.33%95.17%99.07%99.30%
EBT Per EBIT
221.41%152.01%324.55%182.37%101.37%
Return on Assets (ROA)
-21.78%-364.81%-153.98%-52.38%-24.80%
Return on Equity (ROE)
-73.49%125.09%555.33%-256.60%-56.22%
Return on Capital Employed (ROCE)
-13.87%80.45%-3793.75%-36.77%-28.07%
Return on Invested Capital (ROIC)
-11.84%-2263.64%-215.55%-31.92%-26.44%
Return on Tangible Assets
-121.09%-364.81%-153.98%-81.94%-32.40%
Earnings Yield
-1.81%-32.27%-138.66%-12.56%-6.36%
Efficiency Ratios
Receivables Turnover
3.54 3.34 4.12 8.45 45.97
Payables Turnover
3.48 6.89 14.26 21.54 38.12
Inventory Turnover
0.00 11.91 49.11 1.21 3.40
Fixed Asset Turnover
47.89 1.10 14.82 1.94 6.59
Asset Turnover
0.37 0.41 0.41 0.20 0.49
Working Capital Turnover Ratio
-1.92 -0.35 1.38 0.32 1.09
Cash Conversion Cycle
-1.58 87.08 70.41 326.89 105.83
Days of Sales Outstanding
103.20 109.37 88.57 43.22 7.94
Days of Inventory Outstanding
0.00 30.65 7.43 300.61 107.46
Days of Payables Outstanding
104.77 52.94 25.60 16.94 9.57
Operating Cycle
103.20 140.02 96.01 343.83 115.40
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 -0.01 -0.02 >-0.01
Free Cash Flow Per Share
>-0.01 >-0.01 -0.01 -0.02 -0.01
CapEx Per Share
<0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.03 1.12 1.13
Dividend Paid and CapEx Coverage Ratio
-446.50 0.00 -32.95 -8.27 -7.49
Capital Expenditure Coverage Ratio
-446.50 0.00 -32.95 -8.27 -7.49
Operating Cash Flow Coverage Ratio
-1.07 -0.97 -1.02 -1.09 -0.46
Operating Cash Flow to Sales Ratio
-1.51 -7.10 -1.23 -2.01 -0.26
Free Cash Flow Yield
-4.19%-25.50%-46.70%-10.92%-3.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-55.32 -3.10 -0.72 -7.96 -15.72
Price-to-Sales (P/S) Ratio
36.19 27.84 2.72 20.59 7.88
Price-to-Book (P/B) Ratio
51.99 -3.88 -4.01 20.43 8.84
Price-to-Free Cash Flow (P/FCF) Ratio
-23.89 -3.92 -2.14 -9.16 -26.53
Price-to-Operating Cash Flow Ratio
-21.58 -3.92 -2.21 -10.27 -30.07
Price-to-Earnings Growth (PEG) Ratio
-0.65 0.04 -0.02 -0.32 1.83
Price-to-Fair Value
51.99 -3.88 -4.01 20.43 8.84
Enterprise Value Multiple
-66.09 -8.22 -0.56 -10.47 -19.26
Enterprise Value
66.35M 9.55M 4.74M 47.94M 67.71M
EV to EBITDA
-66.09 -8.22 -0.56 -10.47 -19.26
EV to Sales
37.44 34.48 1.91 20.72 7.30
EV to Free Cash Flow
-24.71 -4.86 -1.50 -9.22 -24.57
EV to Operating Cash Flow
-24.77 -4.86 -1.55 -10.33 -27.85
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 >-0.01 0.02
Shareholders’ Equity Per Share
<0.01 >-0.01 >-0.01 <0.01 0.03
Tax and Other Ratios
Effective Tax Rate
-0.01 0.00 0.05 <0.01 >-0.01
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 0.04
Net Income Per Share
>-0.01 >-0.01 -0.03 -0.02 -0.02
Tax Burden
1.01 1.64 0.95 0.99 0.99
Interest Burden
1.01 1.08 1.02 1.04 1.11
Research & Development to Revenue
0.00 0.11 0.09 0.47 0.09
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 -0.03 0.05 0.21
Income Quality
1.03 0.79 0.31 0.77 0.52
Currency in SGD